Renishaw plc (RSW) Fair Value & Analysis
Technology · GB · Market cap 3.5B GBX
Fair value as of: Aug 13, 2026
From 26 valuation models · updated yesterday
Fair value updated Aug 13, 2026, revised from £23.03 to £35.93 (+56.0%) since Jul 19, 2026. Share price +7.6% over the past month.
A solid business, but screening 31% overvalued on our models.
What matters now
- Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (£22.90 to £52.02) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range £21.00 – £54.55 · fair‑value band £22.90 – £52.02 · the £51.75 price screens above the £35.93 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Renishaw plc (RSW) currently trades at £51.75, while our model-based Fair Value estimate is £35.93, implying the stock looks roughly 30.6% overvalued today. The Quality Score stands at 64/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Renishaw plc generated revenue of £737M at a net margin of 10.1%. Revenue grew 7.1% year over year. It earns a return on equity of 8.2%. The balance sheet holds a net cash position of £71.8M. Fundamentals as of Aug 13, 2026
Our scenario range runs from £22.90 (bear case) to £52.02 (bull case); at £51.75, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat. For context, the median of 10 Technology peers we cover trades at -46% fair-value upside, at -31%, RSW screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (£28.72) versus Asset-Based (£8.53). Highest evidence: Growth DCF (80).
Notify me when RSW reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 74
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices.
Full company description
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Renishaw plc reported revenue of £713M in FY2025 versus £567M in FY2021, a compound +5.9%/yr. Reported net income was £83.8M in FY2025, compounding −6.9%/yr from FY2021.
of which total revenue +5.6 pp · buybacks/dilution +0.0 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
RSW screens 31% overvalued. Compare with Keysight Technologies, Inc →
Peer Group
Scientific & Technical Instruments · 168 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Scientific & Technical Instruments median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Keysight Technologies, Inc KEYS | $354.50 | $107.22 | -70% |
| Garmin Ltd GRMN | $309.98 | $139.44 | -55% |
| Teledyne Technologies Incorporated TDY | $686.49 | $488.95 | -29% |
| Chroma ATE Inc 2360 | 2,195 TWD | 322.57 TWD | -85% |
| Hexagon AB HEXAB | kr 95.06 | kr 73.99 | -22% |
| MKS Inc MKSI | $294.38 | $76.00 | -74% |
| AVIC Chengdu Aircraft Company 302132 | ¥57.89 | ¥34.47 | -40% |
| Fortive Corporation FTV | $61.54 | $33.48 | -46% |
| Trimble Inc TRMB | $57.98 | $34.12 | -41% |
| Cognex Corporation CGNX | $60.67 | $19.25 | -68% |
Compare Renishaw plc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Renishaw plc (RSW) overvalued or undervalued?
What is the fair value of RSW?
What is the quality score of RSW?
What is the revenue of Renishaw plc (RSW)?
What is the net profit margin of RSW?
Does Renishaw plc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Renishaw plc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.